SlIde Sets
Explore slide sets below to learn more about dolutegravir and Dovato (dolutegravir/lamivudine)
DOVATO
GEMINI 144 Week Adherence Analysis EACS 2021
View the presentation detailing the GEMINI 144 Week Adherence Analysis data shared at EACS Congress 2021
DOVATO
SALSA 48 Week Subgroup Analysis EACS 2021
View the presentation detailing the SALSA 48 Week Subgroup Analysis data shared at EACS Congress 2021
DOVATO
12 Month URBAN Real-World Cohort EACS 2021
View the presentation detailing the 12 Month URBAN Real-World Cohort data shared at EACS Congress 2021
DOVATO
TANGO 144 Week Subgroup Analysis EACS 2021
View the presentation detailing the TANGO 144 Week Subgroup Analysis data shared at EACS Congress 2021
DOVATO
GEMINI 144 Week Age Analysis EACS 2021
View the presentation detailing the GEMINI 144 Week Age Analysis data shared at EACS Congress 2021
DOVATO
STAT 48wk IDWeek21 presentation
View the presentation sharing the STAT 48-week data shared at ID Week 2021 conference
DOVATO
TANGO 144wk IDWeek21 presentation
View the presentation sharing the TANGO 144-week data shared at ID Week 2021 conference
DOVATO
GEMINI 144-wk TND and Blips analysis (IAS 2021)
A summary of the data presented at IAS 2021 on GEMINI 1&2 144-week study on TND and Blips
DOVATO
STAT (Test and treat) 48-wk study (IAS 2021)
A summary of the data presented at IAS 2021 on the STAT study data at 48 weeks
DOVATO
SALSA 48-wk study (IAS 2021)
A summary of the data presented at IAS 2021 on SALSA 48-wk data switching to DTG/3TC from CAR
DOVATO
TANGO 144-week study (IAS 2021)
A summary of the data presented at IAS 2021 on TANGO 144-week study and metabolic parameters
DOVATO
TANGO 96-week TND and Blips (IAS 2021)
A summary of the data presented at IAS 2021 on TANGO 96 week data for TND and Blips
DOVATO
TANGO subgroup analysis (CROI 2021)
A summary of the data presented at CROI 2021 from the TANGO on the 96 week subgroup data.
DOVATO
GEMINI 1&2 subgroup analysis (CROI 2021)
A summary of the data presented at CROI 2021 from the GEMINI 1&2 studies on the 144 week subgroup data.
DOVATO
GEMINI 1&2 144 week study - HIV Glasgow 2020 Presentation
Learn more about the latest GEMINI 1&2 144 Week study data for Dovato
DOVATO
Real-world data from URBAN study - HIV Glasgow 2020 Presentation
Learn more about the latest Real-world data from URBAN study for Dovato
Other resources
Resources
Watch experts in HIV share the details of Dovato studies and watch internal and external experts share their opinions on the latest data.
Resources
Download bite-size infographics on the latest studies and data to help inform your HIV practice.
PM-GB-HVX-WCNT-200021 v2 | June 2021
